Ataxia, Cerebellar, Cayman Type (ATCAY) Peptide
ATCAY
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN940445
Quick Overview for Ataxia, Cerebellar, Cayman Type (ATCAY) Peptide (ABIN940445)
Target
ATCAY
(Ataxia, Cerebellar, Cayman Type (ATCAY))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- LIPMEHVQIP DCVLQYEEER LKARRESARP QPEFVLPRSE EKPEVAPVEN
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ATCAY antibody,
Alternative Names: ATCAY control peptide, ATCAY antibody Blocking Peptide, Anti-ATCAY Blocking Peptide, ataxia, cerebellar, Cayman type Blocking Peptide, BNIP-H Blocking Peptide, CLAC Blocking Peptide, KIAA1872 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- ATCAY (Ataxia, Cerebellar, Cayman Type (ATCAY))
-
Background
- This gene encodes a neuron-restricted protein that contains a CRAL-TRIO motif common to proteins that bind small lipophilic molecules. Mutations in this gene are associated with cerebellar ataxia, Cayman type.
-
Molecular Weight
- 42 kDa
Target
-
You are here:
